Leading brokers name 3 ASX shares to sell

Blackmores Limited (ASX:BKL) shares and two others have been rated as sells by brokers. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Sunday I looked at three ASX shares that have been given buy ratings by leading brokers this week.

Unfortunately, not all shares are in favour with brokers right now. The three shares listed below have all been given the dreaded sell rating. Here's why:

BHP Group Ltd (ASX: BHP)

According to a note out of Deutsche Bank, its analysts have retained their sell rating and cut the price target on this mining giant's shares to a lowly $28.00 following the release of its third quarter update. The broker cut its price target largely on the back of the company's lower iron ore production due to Tropical Storm Veronica. Deutsche remains bearish on BHP due to its belief that margins have peaked and concerns over the impact of weakness in the Chinese property sector. The miner's shares last trade at $38.23.

Blackmores Limited (ASX: BKL)

A note out of Citi reveals that its analysts have retained their sell rating and trimmed the price target on this health supplements company's shares to $82.50 following its disappointing third quarter update. According to the note, the broker acknowledges that its strong brand and positive tailwinds in China should support its long term growth, but in the near term it has concerns about its marketing and China strategy. Furthermore, despite the sizeable share price pullback, the broker feels its shares are far from cheap. Blackmores' shares last closed at $92.81.

Evolution Mining Ltd (ASX: EVN)

Analysts at Credit Suisse have retained their underperform rating and $2.55 price target on this gold miner's shares following its recent quarterly update. According to the note, Evolution's performance during the quarter was weaker than it expected. And although the company is still on track to achieve the middle of its full year production guidance, it isn't enough for Credit Suisse to make any changes to its recommendation. The Evolution share price closed the week at $3.24.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »